Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, Davis

About this trial

Main study objective: compare long-term buprenorphine treatment outcomes for patients who start buprenorphine for opioid use disorder (OUD) in the emergency department and are then referred to get outpatient buprenorphine treatment either via telehealth or at an in-person clinic.

Researchers will:

Compare rates of establishing outpatient OUD treatment, how long patients stay on buprenorphine, and patients' experience with care to determine whether patient experiences and outcomes are better for patients referred to telehealth treatment versus patients patients referred to in-person treatment after they leave the emergency department.

Participants will:

Be recruited from 3 different hospital emergency departments.

Answer questionnaires at baseline and then 1, 3, 6, and 9 months after their initial emergency department visit.

Eligibility criteria

Qualifiers

Adult patients who present to the emergency department and receive buprenorphine (either administered or prescribed) to treat OUD

do not have an established outpatient clinic where they will get buprenorphine when they leave the emergency department

Disqualifiers

inability to give consent

patients living in institutions (e.g., nursing homes, prisons)

unable to complete questionnaires in either English or Spanish

Trial design

Treatments tested in this trial

  • referral to telehealth treatment
  • referral to in person treatment

Treatment groups

528 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, Davis

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator